Skip to main content

Name
Kiera Liblik

Wed, 02/23/2022 - 18:44

Hello Pierce,
Thank you for a wonderful discussion of last week's MGR. I was doing some reading about the World Health Organization's response to antibiotic resistance.(1) As Dr. Bai discussed, there is a critical need for new and novel ways to counteract antibiotic resistance. Accordingly, governments and global health organizations are providing financial incentives for development in this area.(2)
Interestingly, it seems that one of the barriers to preventing antibiotic resistance in the first place is the inconsistent prescription practices across different medical centres. In Ontario alone, it's been found that types and volume of antibiotics differ greatly between regions. (3) I wonder if you think that it would be worthwhile for the government to put together a committee to decide on definitive antibiotic prescribing practices to be followed at all centres (unless a special case which goes through an appeal). Or, do you think this would be too much paperwork for an insufficient amount of benefit?
Warm regards,
Kiera

1) Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., ... & Zorzet, A. (2018). Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infectious Diseases, 18(3), 318-327.
2) Outterson, K. (2019). A shot in the arm for new antibiotics. Nature biotechnology, 37(10), 1110-1112.
3) Schwartz, K. L., Achonu, C., Brown, K. A., Langford, B., Daneman, N., Johnstone, J., & Garber, G. (2018). Regional variability in outpatient antibiotic use in Ontario, Canada: a retrospective cross-sectional study. Canadian Medical Association Open Access Journal, 6(4), E445-E452.

Name
Kiera Liblik

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.